{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:12:30Z","timestamp":1791389550842,"version":"4.3.3"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Alopecia areata (AA) is a common non-scarring hair loss condition whose specific pathogenesis is not yet fully understood. In children, AA often co-occurs with atopic dermatitis (AD), complicating treatment. Here, we report the case of a child with myasthenia gravis who had severe AA and moderate AD. The child had previously been treated with local injections of corticosteroids and developed total hair loss and AD after discontinuing corticosteroid use. After approximately one year of treatment with baricitinib, 4\u2005mg once daily, combined with twice-daily application of a corticosteroid ointment, a significant improvement in the child's condition was observed, with the Severity of Alopecia Tool score dropping from 100 to 24.4 and Eczema Area Severity Index score to 0. New vellus hairs were clearly observable under trichoscopy, which contrasted significantly with the pre-treatment state. Throughout the treatment process, the patient's clinical symptoms, blood cell counts, liver and kidney function, and coagulation functions were essentially normal, with no significant adverse reactions observed except for folliculitis on the scalp. We discuss common targets in the pathogenesis of AA and AD as well as the safety and prospects of Janus kinase inhibitors for the treatment of pediatric patients with these conditions.<\/jats:p>","DOI":"10.3389\/fped.2024.1497285","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T06:12:30Z","timestamp":1736489550000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis"],"prefix":"10.3389","volume":"12","author":[{"given":"Sihan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhe","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"13231328.e1","DOI":"10.1016\/j.jaip.2020.01.052","article-title":"Alopecia areata is associated with atopic diathesis: results from a population-based study of 51,561 patients","volume":"8","author":"Kridin","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B2","doi-asserted-by":"publisher","first-page":"955035","DOI":"10.3389\/fimmu.2022.955035","article-title":"An overview of JAK\/STAT pathways and JAK inhibition in alopecia areata","volume":"13","author":"Lensing","year":"2022","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/j.jisp.2017.10.014","article-title":"Hair follicle immune privilege revisited: the key to alopecia areata management","volume":"19","author":"Paus","year":"2018","journal-title":"J Investig Dermatol Symp Proc"},{"key":"B4","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/exd.14155","article-title":"Hair follicle immune privilege and its collapse in alopecia areata","volume":"29","author":"Bertolini","year":"2020","journal-title":"Exp Dermatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"16311634.e13","DOI":"10.1016\/j.jaci.2018.06.029","article-title":"An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation","volume":"142","author":"Song","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e434","DOI":"10.1111\/ijd.17288","article-title":"Effectiveness of dupilumab in the treatment of alopecia areata in patients with concurrent atopic dermatitis: a real-life retrospective study","volume":"63","author":"Tavoletti","year":"2024","journal-title":"Int J Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"16774","DOI":"10.1016\/j.jdermsci.2017.07.003","article-title":"Increased frequencies of basophils, type 2 innate lymphoid cells and Th2 cells in skin of patients with atopic dermatitis but not psoriasis","volume":"88","author":"Mashiko","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e98006","DOI":"10.1172\/jci.insight.98006","article-title":"Lipid abnormalities in atopic skin are driven by type 2 cytokines","volume":"3","author":"Berdyshev","year":"2018","journal-title":"JCI Insight"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jaci.2015.06.032","article-title":"Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17\/TH22 skewing","volume":"136","author":"Su\u00e1rez-Fari\u00f1as","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"5318","DOI":"10.3390\/ijms23105318","article-title":"Revisiting the roles of filaggrin in atopic dermatitis","volume":"23","author":"Moosbrugger-Martinz","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1038\/sj.jid.5700915","article-title":"Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease","volume":"127","author":"Betz","year":"2007","journal-title":"J Invest Dermatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.3390\/jcm13113224","article-title":"Depressive disorder and dermatological autoimmune diseases","volume":"13","author":"Pe\u0142a","year":"2024","journal-title":"J Clin Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1177\/12034754231204295","article-title":"The mind body connection in dermatologic conditions: a literature review","volume":"27","author":"Mar","year":"2023","journal-title":"J Cutan Med Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s13555-023-00889-0","article-title":"Alopecia universalis in an adolescent successfully treated with upadacitinib-a case report and review of the literature on the use of JAK inhibitors in pediatric alopecia areata","volume":"13","author":"Ko\u0142cz","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2147\/JAA.S458684","article-title":"Abrocitinib improved dupilumab-resistant severe atopic dermatitis with comorbid mild alopecia areata in a 12-year-old boy: a case report with 1-year follow-up","volume":"17","author":"Liu","year":"2024","journal-title":"J Asthma Allergy"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1111\/jdv.20108","article-title":"Baricitinib therapy for paediatric patients with severe alopecia areata","volume":"39","author":"Zhao","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"6644","DOI":"10.1111\/jocd.15425","article-title":"Efficacy and safety of tofacitinib for treatment of alopecia areata in children: a systematic review and meta-analysis","volume":"21","author":"Behrangi","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.jisp.2020.04.005","article-title":"JAK Inhibitors for the treatment of pediatric alopecia areata","volume":"20","author":"Hamilton","year":"2020","journal-title":"J Investig Dermatol Symp Proc"},{"key":"B19","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/jamadermatol.2023.2581","article-title":"Clinical outcomes for uptitration of baricitinib therapy in patients with severe alopecia areata","volume":"159","author":"Ko","year":"2023","journal-title":"JAMA Dermatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/bjd\/ljad096","article-title":"Efficacy and safety of baricitinib in combination with topical corticosteroids in paediatric patients with moderate-to-severe atopic dermatitis with an inadequate response to topical corticosteroids: results from a phase III, randomized, double-blind, placebo-controlled study (BREEZE-AD PEDS)","volume":"189","author":"Torrelo","year":"2023","journal-title":"Br J Dermatol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1497285\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T06:12:40Z","timestamp":1736489560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1497285\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":20,"alternative-id":["10.3389\/fped.2024.1497285"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1497285","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"article-number":"1497285"}}